Endo International
Endo International was a specialty pharmaceutical company best known for Xiaflex (collagenase clostridium histolyticum), branded urology and orthopedic products, and a large sterile-injectables and generics business (Par Pharmaceutical). Endo filed Chapter 11 in August 2022 amid mass opioid litigation tied to its legacy Opana ER franchise, and emerged in April 2024 as the private company Endo, Inc., owned by its former creditors. On July 31, 2025, Endo combined with Mallinckrodt; the merged group then separated in November 2025 into two independent companies — Keenova Therapeutics (specialty branded therapeutics, including the former Endo Xiaflex/urology/orthopedics portfolio and Mallinckrodt specialty brands) and Par Health (generics, sterile injectables, and pharmaceutical Active Pharmaceutical Ingredients manufacturing). Endo no longer operates as a standalone public-facing pharmaceutical company. There is no public developer program, OpenAPI specification, SDK, or technology API surface associated with Endo, the post-emergence Endo Inc, Keenova Therapeutics, or Par Health. Any references to "API" on the successor companies' sites refer to pharmaceutical Active Pharmaceutical Ingredients, not software application programming interfaces.
Index entry only — little beyond a description and a link, and nothing machine-readable enough for an agent to act on without a human reading the site first.
API Evangelist profiles Endo International the way a machine reads it — 1 machine-readable artifact, pulled from the provider's own public surface and indexed so a developer, an analyst, or an AI agent can evaluate it against every other provider on the network.
Every provider in the network is reduced to the same set of machine-readable artifacts — OpenAPI contracts, event specifications, GraphQL schemas, runnable collections, pricing and rate-limit signals, security posture, OAuth scopes, and the agent surfaces (MCP servers and skills) that let software drive the API on its own. We profile them because the interface is the part of a company you can actually inspect: it is a truer signal of what a provider does than any marketing page. From those artifacts we compute the Kin Score — Endo International scores 6.8/100 (minimal), with a separate agent-readiness read of 0/100 (human only). The full breakdown is below, followed by every artifact we hold — each card links through to its machine-readable definition on apis.io.
Kin Score
This is the API Evangelist rating — a single, repeatable read computed from the artifacts on this page. Green fill is points earned; the red track is points possible, so every bar shows earned-versus-possible at a glance.
Kin Score
How this is scored →scored 2026-07-27 · rubric v0.5
How we profile Endo International
Each block below is one kind of artifact we hold for Endo International. For each we say what it is and why it earns a place in the profile, then list every one we've indexed — capped at two rows, scroll within the panel for the rest.
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals — the evidence that a provider takes security seriously enough to document it. We profile it because you can't govern what you can't see.
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Every other property we hold for Endo International — documentation, portals, status pages, policies, and corporate surface — grouped by the job it does, following the integrator's arc from getting started to running in production.
Access & Security 1
Authentication, authorization, and security posture
Company 5
The organization behind the API
Other 3
Properties that don't map to a standard resource type
← All providers · Data indexed from github.com/api-evangelist/endo-international · machine-readable index on apis.io